Your browser doesn't support javascript.
loading
Clinical impacts of frailty, poor performance status, and advanced age in carfilzomib-containing treatment for relapsed/refractory multiple myeloma: post hoc investigation of the KOTOSG multicenter pilot prospective observational study.
Kawaji-Kanayama, Yuka; Muramatsu, Ayako; Sasaki, Nana; Shimura, Kazuho; Kiyota, Miki; Fuchida, Shinichi; Isa, Reiko; Fujino, Takahiro; Matsumura-Kimoto, Yayoi; Tsukamoto, Taku; Chinen, Yoshiaki; Mizutani, Shinsuke; Nakao, Mitsushige; Kaneko, Hiroto; Kawata, Eri; Hirakawa, Koichi; Takahashi, Ryoichi; Shimazaki, Chihiro; Uchiyama, Hitoji; Uoshima, Nobuhiko; Shimura, Yuji; Kobayashi, Tsutomu; Taniwaki, Masafumi; Kuroda, Junya.
Affiliation
  • Kawaji-Kanayama Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Muramatsu A; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Sasaki N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Shimura K; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan.
  • Kiyota M; Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan.
  • Fuchida S; Department of Hematology, Japan Community Health Care Organization, Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
  • Isa R; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Fujino T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Matsumura-Kimoto Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Tsukamoto T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Chinen Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Mizutani S; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Nakao M; Department of Internal Medicine, Otsu Municipal Hospital, Otsu, Japan.
  • Kaneko H; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan.
  • Kawata E; Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan.
  • Hirakawa K; Department of Hematology, Fukuchiyama City Hospital, Fukuchiyama, Japan.
  • Takahashi R; Department of Hematology, Omihachiman Community Medical Center, Omihachiman, Japan.
  • Shimazaki C; Department of Hematology, Japan Community Health Care Organization, Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
  • Uchiyama H; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Shimura Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Kobayashi T; Department of Blood Transfusion, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Taniwaki M; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
Int J Hematol ; 115(3): 350-362, 2022 Mar.
Article in En | MEDLINE | ID: mdl-35072907
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Psychomotor Performance / Frailty / Multiple Myeloma / Antineoplastic Agents Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Hematol Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: Japón
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Psychomotor Performance / Frailty / Multiple Myeloma / Antineoplastic Agents Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Hematol Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: Japón